纳米战略与局部区域干预疗法协同作用,以提高抗瘤免疫力
Ting Luo1,2, Kunpeng Ma3, Yi Zhang1
1Department of Interventional Ultrasound, Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, PR China.
Bioactive materials
|June 16, 2025
概括
地方区域干预疗法 (LIT) 提供具有免疫效益的微创癌症治疗. 将LIT与免疫疗法和新型纳米策略相结合,可以增强针对个性化癌症护理的抗瘤免疫力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
背景情况:
- 传统的癌症治疗方法,如手术,化疗和放射治疗都有局限性.
- 地方区域干预疗法 (LIT) 提供具有免疫调节潜力的微创替代方案.
- 将LIT与免疫疗法结合起来是改善癌症治疗的有希望的策略.
研究的目的:
- 审查当前的免疫-地方区域干预疗法 (免疫-LIT) 组合.
- 讨论这些联合疗法的免疫调节作用.
- 提出新的纳米战略,与免疫LIT协同工作.
主要方法:
- 关于免疫-LIT组合的文献综述.
- 免疫调节机制的分析.
- 探索纳米医学在癌症治疗中的应用.
主要成果:
- 包括局部切除和血管内干预在内的LIT可以有效地与免疫治疗相结合.
- 生物相容纳米材料在调节抗瘤免疫力方面显示出潜力.
- 纳米材料和免疫-LIT之间的协同效应可以提高治疗效率.
结论:
- 通过纳米战略增强的免疫-LIT组合,为个性化癌症治疗提供了一个有希望的途径.
- 这些方法的进一步优化和临床转化至关重要.
- 这种组合疗法有可能显著有益于癌症患者.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.3K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.7K
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
